Kura Oncology, Inc. - FORM 10-Q - EX-32.2 - CERTIFICATION OF THE COMPANY?S PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002. - August 14, 2013

Attached files

file filename
EX-10.1 - PROMISSORY NOTE ISSUED TO AANA LTD. ON JUNE 28, 2013. - Kura Oncology, Inc.f10q0613ex10i_zetacorpiii.htm
EX-10.4 - PROMISSORY NOTE ISSUED TO JOHN PAPPAJOHN ON JUNE 20, 2013. - Kura Oncology, Inc.f10q0613ex10iv_zetacorpiii.htm
EX-10.2 - PROMISSORY NOTE ISSUED TO NICALE PARTNERS ON JUNE 28, 2013. - Kura Oncology, Inc.f10q0613ex10ii_zetacorpiii.htm
EX-10.3 - PROMISSORY NOTE ISSUED TO MATTHEW P. KINLEY ON JUNE 28, 2013. - Kura Oncology, Inc.f10q0613ex10iii_zetacorpiii.htm
EXCEL - IDEA: XBRL DOCUMENT - Kura Oncology, Inc.Financial_Report.xls
EX-31.2 - CERTIFICATION OF THE COMPANY?S PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002, WITH RESPECT TO THE REGISTRANT?S QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2013. - Kura Oncology, Inc.f10q0613ex31ii_zetacorpiii.htm
10-Q - QUARTERLY REPORT - Kura Oncology, Inc.f10q0613_zetacorpiii.htm
EX-32.1 - CERTIFICATION OF THE COMPANY?S PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002. - Kura Oncology, Inc.f10q0613ex32i_zetacorpiii.htm
EX-31.1 - CERTIFICATION OF THE COMPANY?S PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002, WITH RESPECT TO THE REGISTRANT?S QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTER ENDED JUNE 30, 2013. - Kura Oncology, Inc.f10q0613ex31i_zetacorpiii.htm
Exhibit 32.2

Certification of Principal Financial Officer
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to
Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Quarterly Report of Zeta Acquisition Corp. III (the "Company") on Form 10-Q for the period ended June 30, 2013 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Matthew P. Kinley, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 
/s/ Matthew P. Kinley
 
Matthew P. Kinley
Principal Financial Officer
August 14, 2013
 

Kura Oncology, Inc. Reports